Company Overview

Business Description

Sector
Health Care
Industry
Life Sciences Tools & Services
Headquarters
United States of America US
Employees
3 100
IPO date
Feb 9, 1989

Bio-Techne makes the tools scientists use to study cells and disease. Its products include antibodies, proteins, assays, cell and gene therapy reagents, and instruments used in life-science research and clinical testing. The company also sells diagnostic products that help labs detect and monitor certain medical conditions.

Its main customers are drug developers, academic and government research labs, biotech companies, and clinical laboratories. Bio-Techne makes money by selling these consumable products, along with instruments and related services, through direct sales and distributors. Because many of its products are used repeatedly in research and testing workflows, it plays a steady supplier role in the life-science supply chain.

What makes Bio-Techne different is that it sits close to the basic science stage of medicine. Instead of making finished drugs, it sells the specialized materials and testing tools that other companies and labs need to discover, develop, and validate those drugs and diagnostics. That gives it exposure to a wide range of research and healthcare end markets.

Bio-Techne Corp Investor Relations

Address
614 Mckinley Pl N E, Suite 1500
Minneapolis, Minnesota
United States of America

Business Segments

Protein sciences

This segment sells proteins, antibodies, assay kits, and related research tools used to study how cells and tissues behave.

Customers and revenue model

Diagnostics and spatial biology

This segment sells diagnostic test components, quality control materials, and spatial biology tools that help labs and researchers detect disease markers and map where molecules and cells are located in tissue.

Customers and revenue model

Management

Mr. Kim Kelderman

CEO, President & Director

Biography unavailable

Mr. James T. Hippel CPA

Executive VP of Finance & CFO

Biography unavailable

Mr. Shane Bohnen

Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer

Biography unavailable

Mr. William A. Geist

President of Protein Sciences Segment

Biography unavailable

Dr. Matthew F. McManus M.D., MBA, Ph.D.

President of Diagnostics & Genomics

Biography unavailable

Dr. Gary J. Latham Ph.D.

VP & CTO

Biography unavailable

Mr. David Clair C.F.A.

Senior Director of Investor Relations & Corporate Development

Biography unavailable

Mr. Gerry Andros

Vice President of Sales and Marketing

Biography unavailable

Mr. Martin Wirtz

Senior Vice President of Strategy & Corporate Development

Biography unavailable

Ms. Cheryl Bethune

Senior VP & Chief Human Resources Officer

Biography unavailable

1 / 10